Search
eacs_interim_guidance_on_stati...
These recommendations have been developed by representatives from the Comorbidities panel of the EACS Guidelines to inform the use of statin therapy for the ...
O statină este de preferat în terapia de primă linie; diferite statine au ... 2) medicamente hipolipemiante (statine, fibrate), 3) antihipertensive ...
https://www.eacsociety.org/media/guidelines-7.1-romanian.pdf
leitlinien - guidelines - European AIDS Clinical Society (EACS)
Statine sollten bei allen Personen mit Gefäßer- krankungen, mit Typ-2-Diabetes oder einem hohen Risiko für eine HKL-Er- krankung unabhängig von den ...
https://www.eacsociety.org/media/guidelines-10.0_final_german.pdf
RECOMMANDATIONS - European AIDS Clinical Society (EACS)
Une statine est le traitement de choix en première ligne, les différentes ... (=diminution de l'activité de la statine, ↑ la dose par pallier pour.
This EACS Interim Guidance has been developed to inform the use of statin therapy for the primary prevention of cardiovascular disease in people with HIV in ...
GHID - European AIDS Clinical Society (EACS)
La persoanele cu risc înalt care prezintă intoleranță la statine, interacțiuni medicamentoase între statinele de intensi- tate mare și ARV sau la care nu se pot ...
https://www.eacsociety.org/media/eacs_guidelines_v12_romanian.pdf
novembre 2012 - European AIDS Clinical Society (EACS)
I farmaci ART possono inibire v (tossicità da statine, ↓ dose) o aumentare vi (=minor effetto delle statine, ↑ dose gradualmente per ottenere il beneficio ...
https://www.eacsociety.org/media/2012_eacsguidelines-v6.1-italian_nov.pdf
RECOMMANDATIONS Version 9.0 Octobre 2017
(=diminution de l'activité de la statine, ↑ la dose par pallier pour atteindre le bénéfice attendu ii, iii) l'excrétion de la statine associée. vii.
(=diminution de l'activité de la statine, ↑ la dose par pallier pour atteindre le bénéfice attendu ii, iii) l'excrétion de la statine associée. vii.
https://www.eacsociety.org/media/guidelines_10.0_french__1_.pdf
... Statine(i,ix) atorvastatine(ii). 10-80 mgx 1/j. Troubles gastro- intestinaux, céphalées, insomnies, rhabdomyolyse (rare) et hépatite toxique. Démarrer à faible.
EACS Guidelines update now available!
The EACS v13.1 and the app are available for free on
Educational Programme
Training and educating the next generation of clinicians and researchers is an EACS core activity.